Ascentage Pharma Group International American Depository Shares When Issued
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibit… Read more
Market Cap & Net Worth: Ascentage Pharma Group International American Depository Shares When Issued (AAPGV)
Ascentage Pharma Group International American Depository Shares When Issued (NASDAQ:AAPGV) has a market capitalization of $204.57K ($204.57K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #39477 globally and #12858 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ascentage Pharma Group International American Depository Shares When Issued's stock price $21.65 by its total outstanding shares 9449 (9.45K).
Ascentage Pharma Group International American Depository Shares When Issued Market Cap History: 2025 to 2025
Ascentage Pharma Group International American Depository Shares When Issued's market capitalization history from 2025 to 2025. Data shows growth from $204.57K to $204.57K (0.00% CAGR).
Ascentage Pharma Group International American Depository Shares When Issued Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ascentage Pharma Group International American Depository Shares When Issued's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AAPGV by Market Capitalization
Companies near Ascentage Pharma Group International American Depository Shares When Issued in the global market cap rankings as of March 19, 2026.
Key companies related to Ascentage Pharma Group International American Depository Shares When Issued by market ranking:
- Sydinv Formue Balance Akk A (CO:SYVFBAKKA): Ranked #39468 globally with a market cap of $198.64K USD ( Dkr1.44 Million DKK).
- Dongnam Chemical Co. Ltd. (KQ:023450): Ranked #39469 globally with a market cap of $198.47K USD ( ₩290.60 Million KRW).
- SCANDIN.ENVIRO SYSTEMS AB (F:1HR): Ranked #39478 globally with a market cap of $197.30K USD ( €192.21K EUR).
- OXFORD LANE CAP.CORP.DL25 (F:4RQ0): Ranked #39479 globally with a market cap of $197.24K USD ( €192.15K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #39468 | Sydinv Formue Balance Akk A | CO:SYVFBAKKA | $198.64K | Dkr145.45 |
| #39469 | Dongnam Chemical Co. Ltd. | KQ:023450 | $198.47K | ₩30800.00 |
| #39478 | SCANDIN.ENVIRO SYSTEMS AB | F:1HR | $197.30K | €0.00 |
| #39479 | OXFORD LANE CAP.CORP.DL25 | F:4RQ0 | $197.24K | €21.00 |
Ascentage Pharma Group International American Depository Shares When Issued Historical Marketcap From 2025 to 2025
Between 2025 and today, Ascentage Pharma Group International American Depository Shares When Issued's market cap moved from $204.57K to $ 204.57K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $204.57K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ascentage Pharma Group International American Depository Shares When Issued was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $204.57K USD |
| MoneyControl | $204.57K USD |
| MarketWatch | $204.57K USD |
| marketcap.company | $204.57K USD |
| Reuters | $204.57K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.